Morgan Adams Foundation

Recent papers from Morgan Adams Foundation

1. A Trifecta of Combining innate and adaptive checkpoint blockadeNeuro-Oncology · 2026
2. Early increase in apparent diffusion coefficient predicts favorable response to Dordaviprone (ONC201) therapy in H3K27M-mutant diffuse midline gliomaNeuro-Oncology · 2026
3. ID #1043 BioBombe-Guided Pathway Analysis Identifies Candidate Therapeutics in Pediatric High-Grade GliomaNeuro-Oncology Pediatrics · 2026
4. ID #941 Tumoroids as models of pediatric high-grade glioma: comparative sequencing, in vitro drug testing, and co-culture modelingNeuro-Oncology Pediatrics · 2026
5. ID #920 Combination XPO1 inhibition and cellular immunotherapy for the treatment of pediatric high-grade gliomasNeuro-Oncology Pediatrics · 2026
6. ID #734 Phagocytic Context Dictates Macrophage Fate in Malignant GliomasNeuro-Oncology Pediatrics · 2026
7. ID #1019 Initial Results from a Phase 1/2 Trial of Selinexor and Radiation in Newly Diagnosed Pediatric High-Grade Glioma and Diffuse Midline Glioma: A Children’s Oncology Group TrialNeuro-Oncology Pediatrics · 2026
8. ID #194 Development and validation of a standardized step-by-step manual segmentation protocol for hypothalamic volume in pediatric craniopharyngiomaNeuro-Oncology Pediatrics · 2026
9. ID #990 Using an in utero electroporation model of thalamic diffuse midline glioma to investigate the mechanisms governing tumorigenesis, therapeutic response, and resistanceNeuro-Oncology Pediatrics · 2026
10. ID #419 Exploiting nuclear exportin-1 as a therapeutic vulnerability in atypical teratoid rhabdoid tumorsNeuro-Oncology Pediatrics · 2026
11. ID #857 Establishiment of the Radiation-Induced Glioma Registry (RIG-R)Neuro-Oncology Pediatrics · 2026
12. Overview of surgical approaches and adjuvant therapy for treatment of craniopharyngiomasThe Journal of Clinical Endocrinology & Metabolism · 2026
13. Microglia in diffuse midline glioma contribute to extracellular matrix remodelling and cancer cell invasionCell Death and Disease · 2026
14. Medical Record-Level Evaluation of Impact of Demographic and Socioeconomic Factors on Pediatric Neuro-Oncology Outcomes at a Large Regional Children’s HospitalNeuro-Oncology Pediatrics · 2026
15. Tempered Optimism: Advances in the Precision Medicine Era for Pediatric Low-Grade GliomaNeuro-Oncology · 2026
16. hTERT Expression, Regulation, and Prognostic Significance in Pediatric Medulloblastoma2026
17. Molecular Biology and Phase 1 Study of GM-CSF and Intrathecal Trastuzumab in Children with Recurrent Posterior Fossa EpendymomaNeuro-Oncology · 2026
18. CNSC-04. A prognostic human brain network for diffuse midline gliomaNeuro-Oncology Pediatrics · 2025
19. EPEN-06. Single cell resolution spatial transcriptomic analysis of PFA ependymoma reveals appearance of a proliferative UEC-A progenitor subpopulation at recurrenceNeuro-Oncology Pediatrics · 2025
20. CP-03. Sex-associated differences in disease progression and functional outcomes of adamantinomatous craniopharyngioma in prepubescent patientsNeuro-Oncology Pediatrics · 2025